DownloadHi-Res Photo

Dan Oren, MD, BS

Associate Professor of Psychiatry (Adjunct)

Research & Publications
Biography
News

Coauthors

Selected Publications

Carbon monoxide: a critical physiological regulator sensitive to lightOren DA, Sit DK, Goudarzi SH, Wisner KL. Carbon monoxide: a critical physiological regulator sensitive to light. Translational Psychiatry 2020, 10: 87. PMID: 32152296, PMCID: PMC7062897, DOI: 10.1038/s41398-020-0766-1.
Changes in melatonin synthesis parameters after carbon monoxide concentration increase in the cavernous sinus.Romerowicz-Misielak M, Oren D, Sowa-Kucma M, Tabecka-Lonczynska A, Gilun P, Stefanczyk-Krzymowska S, Koziorowski M. Changes in melatonin synthesis parameters after carbon monoxide concentration increase in the cavernous sinus. Journal Of Physiology And Pharmacology 2015, 66: 505-14. PMID: 26348075.
SAD and the Not-So-Single PhotoreceptorsOren DA, Koziorowski M, Desan PH. SAD and the Not-So-Single Photoreceptors. American Journal Of Psychiatry 2013, 170: 1403-1412. PMID: 23929223, DOI: 10.1176/appi.ajp.2013.13010111.
Multicenter, randomized, double‐blind, active comparator and placebo‐controlled trial of a corticotropin‐releasing factor receptor‐1 antagonist in generalized anxiety disorderCoric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, Wu X, Gentile KA, Huang S, Emison E, Delmonte T, D'Souza BB, Zimbroff DL, Grebb JA, Goddard AW, Stock EG. Multicenter, randomized, double‐blind, active comparator and placebo‐controlled trial of a corticotropin‐releasing factor receptor‐1 antagonist in generalized anxiety disorder. Depression And Anxiety 2010, 27: 417-425. PMID: 20455246, DOI: 10.1002/da.20695.
Light and non-visual photoreceptionOren D, Desan P. Light and non-visual photoreception. 2009, 131-142. DOI: 10.1093/med/9780199544288.003.0008.
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled studyYoung A, Oren D, Lowy A, McQuade R, Marcus R, Carson W, Spiller N, Torbeyns A, Sanchez R. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. The British Journal Of Psychiatry 2009, 194: 40-48. PMID: 19118324, DOI: 10.1192/bjp.bp.108.049965.
A Randomized, Double-Blind, Placebo-Controlled Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients With Alzheimer's, Vascular, or Mixed DementiaRappaport S, Marcus R, Manos G, McQuade R, Oren D. A Randomized, Double-Blind, Placebo-Controlled Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients With Alzheimer's, Vascular, or Mixed Dementia. Journal Of The American Medical Directors Association 2008, 10: 21-27. PMID: 19111849, DOI: 10.1016/j.jamda.2008.06.006.
Intramuscular Aripiprazole for the Treatment of Acute Agitation Associated with Schizophrenia: Sub-analysis of a Double-blind, Controlled, Dose-ranging StudyKungel M, Czaniera R, Ebrecht M, Werner C, Oren D, McQuade R, Modell S. Intramuscular Aripiprazole for the Treatment of Acute Agitation Associated with Schizophrenia: Sub-analysis of a Double-blind, Controlled, Dose-ranging Study. Pharmacopsychiatry 2007, 40 DOI: 10.1055/s-2007-991772.
Efficacy and Safety of Oral Aripiprazole Compared with Haloperidol in Patients Transitioning from Acute Treatment with Intramuscular FormulationsDANIEL D, CURRIER G, ZIMBROFF D, ALLEN M, OREN D, MANOS G, MCQUADE R, PIKALOV A, CRANDALL D. Efficacy and Safety of Oral Aripiprazole Compared with Haloperidol in Patients Transitioning from Acute Treatment with Intramuscular Formulations. Journal Of Psychiatric Practice 2007, 13: 170-177. PMID: 17522560, DOI: 10.1097/01.pra.0000271658.86845.81.
Intramuscular Aripiprazole in the Control of AgitationCURRIER G, CITROME L, ZIMBROFF D, OREN D, MANOS G, MCQUADE R, PIKALOV A, CRANDALL D. Intramuscular Aripiprazole in the Control of Agitation. Journal Of Psychiatric Practice 2007, 13: 159-169. PMID: 17522559, DOI: 10.1097/01.pra.0000271657.09717.e2.
Management of Acute Agitation in Patients With Bipolar DisorderZimbroff D, Marcus R, Manos G, Stock E, McQuade R, Auby P, Oren D. Management of Acute Agitation in Patients With Bipolar Disorder. Journal Of Clinical Psychopharmacology 2007, 27: 171-176. PMID: 17414241, DOI: 10.1097/jcp.0b13e318033bd5e.
Intramuscular aripiprazole for the treatment of acute agitation associated with schizophrenia: Sub-analysis of a double-blind, controlled, dose-ranging studyOren D, Manos G, Markovic O, McQuade R. Intramuscular aripiprazole for the treatment of acute agitation associated with schizophrenia: Sub-analysis of a double-blind, controlled, dose-ranging study. European Psychiatry 2007, 22: s124. DOI: 10.1016/j.eurpsy.2007.01.397.
Transitioning from intramuscular (IM) to oral aripiprazole in patients with schizophreniaDaniel D, Markovic O, Crandall D, Manos G, McQuade R, Gutierrez-Esteinou R, Pikalov A, Oren D. Transitioning from intramuscular (IM) to oral aripiprazole in patients with schizophrenia. European Psychiatry 2007, 22: s124-s125. DOI: 10.1016/j.eurpsy.2007.01.398.
Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.Tran-Johnson T, Sack D, Marcus R, Auby P, McQuade R, Oren D. Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial. The Journal Of Clinical Psychiatry 2007, 68: 111-9. PMID: 17284138, DOI: 10.4088/jcp.v68n0115.
Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.Robinson D, Gilmor M, Yang Y, Moonsammy G, Azzaro A, Oren D, Campbell B. Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials. Psychopharmacology Bulletin 2007, 40: 15-28. PMID: 18007565.
Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study*Andrezina R, Marcus R, Oren D, Manos G, Stock E, Carson W, McQuade R. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study*. Current Medical Research And Opinion 2006, 22: 2209-2219. PMID: 17076982, DOI: 10.1185/030079906x148445.
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidolAndrezina R, Josiassen R, Marcus R, Oren D, Manos G, Stock E, Carson W, Iwamoto T. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology 2006, 188: 281-292. PMID: 16953381, DOI: 10.1007/s00213-006-0541-x.
Tyramine Pressor Sensitivity During Treatment With the Selegiline Transdermal System 6 mg/24 h in Healthy SubjectsAzzaro A, VanDenBerg C, Blob L, Kemper E, Sharoky M, Oren D, Campbell B. Tyramine Pressor Sensitivity During Treatment With the Selegiline Transdermal System 6 mg/24 h in Healthy Subjects. The Journal Of Clinical Pharmacology 2006, 46: 933-944. PMID: 16855078, DOI: 10.1177/0091270006289852.
Circadian Phase Shifting, Alerting, and Antidepressant Effects of Bright Light TreatmentPostolache T, Oren D. Circadian Phase Shifting, Alerting, and Antidepressant Effects of Bright Light Treatment. Clinics In Sports Medicine 2005, 24: 381-413. PMID: 15892931, DOI: 10.1016/j.csm.2004.12.005.
Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings.Epperson CN, Terman M, Terman JS, Hanusa BH, Oren DA, Peindl KS, Wisner KL. Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. The Journal Of Clinical Psychiatry 2004, 65: 421-5. PMID: 15096083, DOI: 10.4088/jcp.v65n0319.
Addition of the α2-Antagonist Yohimbine to Fluoxetine: Effects on Rate of Antidepressant ResponseSanacora G, Berman RM, Cappiello A, Oren DA, Kugaya A, Liu N, Gueorguieva R, Fasula D, Charney DS. Addition of the α2-Antagonist Yohimbine to Fluoxetine: Effects on Rate of Antidepressant Response. Neuropsychopharmacology 2004, 29: 1166-1171. PMID: 15010697, DOI: 10.1038/sj.npp.1300418.
Brightening DepressionWirz-Justice A, Terman M, Oren D, Goodwin F, Kripke D, Whybrow P, Wisner K, Wu J, Lam R, Berger M, Danilenko K, Kasper S, Smeraldi E, Takahashi K, Thompson C, van den Hoofdakker R. Brightening Depression. Science 2004, 303: 467-469. PMID: 14739440, DOI: 10.1126/science.303.5657.467c.
Regional Brain Metabolic Correlates of α-Methylparatyrosine–Induced Depressive Symptoms: Implications for the Neural Circuitry of DepressionBremner JD, Vythilingam M, Ng CK, Vermetten E, Nazeer A, Oren DA, Berman RM, Charney DS. Regional Brain Metabolic Correlates of α-Methylparatyrosine–Induced Depressive Symptoms: Implications for the Neural Circuitry of Depression. JAMA 2003, 289: 3125-3134. PMID: 12813118, PMCID: PMC3233764, DOI: 10.1001/jama.289.23.3125.
Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depressionBoutros NN, Gueorguieva R, Hoffman RE, Oren DA, Feingold A, Berman RM. Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression. Psychiatry Research 2002, 113: 245-254. PMID: 12559481, DOI: 10.1016/s0165-1781(02)00267-6.
An Open Trial of Morning Light Therapy for Treatment of Antepartum DepressionOren D, Wisner K, Spinelli M, Epperson C, Peindl K, Terman J, Terman M. An Open Trial of Morning Light Therapy for Treatment of Antepartum Depression. American Journal Of Psychiatry 2002, 159: 666-669. PMID: 11925310, DOI: 10.1176/appi.ajp.159.4.666.
Monoamine depletion in unmedicated depressed subjectsBerman RM, Sanacora G, Anand A, Roach LM, Fasula MK, Finkelstein CO, Wachen RM, Oren DA, Heninger GR, Charney DS. Monoamine depletion in unmedicated depressed subjects. Biological Psychiatry 2002, 51: 469-473. PMID: 11922881, DOI: 10.1016/s0006-3223(01)01285-9.
Bright Light Therapy for Schizoaffective DisorderOREN D, CUBELLS J, LITSCH S. Bright Light Therapy for Schizoaffective Disorder. American Journal Of Psychiatry 2001, 158: 2086-a-2087. PMID: 11729035, DOI: 10.1176/appi.ajp.158.12.2086-a.
Is Seasonal Affective Disorder a Disorder of Circadian Rhythms?Desan P, Oren D. Is Seasonal Affective Disorder a Disorder of Circadian Rhythms? CNS Spectrums 2001, 6: 487-501. PMID: 15744212, DOI: 10.1017/s1092852900008038.
Visual Impairment and Patterns of Winter Seasonal Depression: Seeing the Light?Oren D, Zulman D, Needham W, Berman R, Anand A, Charney D. Visual Impairment and Patterns of Winter Seasonal Depression: Seeing the Light? Journal Of Visual Impairment & Blindness 2001, 95: 226-229. DOI: 10.1177/0145482x0109500404.
Stimulation of reactive oxygen species production by an antidepressant visible light sourceOren D, Charney D, Lavie R, Sinyakov M, Lubart R. Stimulation of reactive oxygen species production by an antidepressant visible light source. Biological Psychiatry 2001, 49: 464-467. PMID: 11274659, DOI: 10.1016/s0006-3223(00)01106-9.
No effect of light on basal glucagon levels in winter seasonal depressives and comparison subjectsOren D, Berman R, Anand A, Charney D. No effect of light on basal glucagon levels in winter seasonal depressives and comparison subjects. Psychiatry Research 2000, 94: 263-266. PMID: 10889291, DOI: 10.1016/s0165-1781(00)00158-x.
Genetic polymorphism at the CLOCK gene locus and major depressionDesan P, Oren D, Malison R, Price L, Rosenbaum J, Smoller J, Charney D, Gelernter J. Genetic polymorphism at the CLOCK gene locus and major depression. American Journal Of Medical Genetics 2000, 96: 418-421. PMID: 10898925, DOI: 10.1002/1096-8628(20000612)96:3<418::aid-ajmg34>3.0.co;2-s.
268. Simultaneous catecholamine and indoleamine depletion in unmedicated depressed subjectsBerman R, Sanacora G, Narasimhan M, Oren D, Cappiello A, Charney D. 268. Simultaneous catecholamine and indoleamine depletion in unmedicated depressed subjects. Biological Psychiatry 2000, 47: s81. DOI: 10.1016/s0006-3223(00)00532-1.
Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine: Support for Hyperglutamatergic Effects of N-methyl-D-aspartate Receptor AntagonistsAnand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A, Krystal JH. Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine: Support for Hyperglutamatergic Effects of N-methyl-D-aspartate Receptor Antagonists. JAMA Psychiatry 2000, 57: 270-276. PMID: 10711913, DOI: 10.1001/archpsyc.57.3.270.
Antidepressant effects of ketamine in depressed patientsBerman R, Cappiello A, Anand A, Oren D, Heninger G, Charney D, Krystal J. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 2000, 47: 351-354. PMID: 10686270, DOI: 10.1016/s0006-3223(99)00230-9.
Transient Depressive Relapse Induced by Catecholamine Depletion: Potential Phenotypic Vulnerability Marker?Berman RM, Narasimhan M, Miller HL, Anand A, Cappiello A, Oren DA, Heninger GR, Charney DS. Transient Depressive Relapse Induced by Catecholamine Depletion: Potential Phenotypic Vulnerability Marker? JAMA Psychiatry 1999, 56: 395-403. PMID: 10232292, DOI: 10.1001/archpsyc.56.5.395.
The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trialBerman R, Anand A, Cappiello A, Miller H, Hu X, Oren D, Charney D. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Biological Psychiatry 1999, 45: 1170-1177. PMID: 10331109, DOI: 10.1016/s0006-3223(98)00383-7.
Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorderAnand A, Darnell A, Miller H, Berman R, Cappiello A, Oren D, Woods S, Charney D. Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder. Biological Psychiatry 1999, 45: 972-978. PMID: 10386179, DOI: 10.1016/s0006-3223(98)00293-5.
There Is Nothing New Under the SunOREN D. There Is Nothing New Under the Sun. American Journal Of Psychiatry 1999, 156: 336-336. PMID: 9989577, DOI: 10.1176/ajp.156.2.336.
Seasonal affective disorderZulman D, Oren D. Seasonal affective disorder. Current Opinion In Psychiatry 1999, 12: 81-86. DOI: 10.1097/00001504-199901000-00022.
Seasons on the MindOren D, Charney D. Seasons on the Mind. Psychiatric Annals 1998, 28: 423-423. DOI: 10.3928/0048-5713-19980801-03.
Carbon monoxide poisoning and treatment with hyperbaric oxygen in the subacute phaseCoric V, Oren D, Wolkenberg F, Kravitz R. Carbon monoxide poisoning and treatment with hyperbaric oxygen in the subacute phase. Journal Of Neurology Neurosurgery & Psychiatry 1998, 65: 245. PMID: 9703180, PMCID: PMC2170185, DOI: 10.1136/jnnp.65.2.245.
Heisenberg meets photobiology?Oren D. Heisenberg meets photobiology? Science 1998, 279: 969. PMID: 9490481, DOI: 10.1126/science.279.5353.963h.
Tweaking the human circadian clock with light.Oren D, Terman M. Tweaking the human circadian clock with light. Science 1998, 279: 333-4. PMID: 9454328, DOI: 10.1126/science.279.5349.333.
P.6.073 Photons, CNS, and the possible role of absorbing and fluorescent substances; is our brain an “Optocybernetic system”?Grass F, Oren D, Klima H, Kasper S. P.6.073 Photons, CNS, and the possible role of absorbing and fluorescent substances; is our brain an “Optocybernetic system”? European Neuropsychopharmacology 1997, 7: s286-s287. DOI: 10.1016/s0924-977x(97)88949-3.
P.1.141 Humoral phototransduction.: Is albumine involved?Grass F, Oren D, Huber W, Kasper S. P.1.141 Humoral phototransduction.: Is albumine involved? European Neuropsychopharmacology 1997, 7: s180. DOI: 10.1016/s0924-977x(97)88590-2.
Effects of Meta-chlorophenylpiperazine Infusions in Patients With Seasonal Affective Disorder and Healthy Control Subjects: Diurnal Responses and Nocturnal Regulatory MechanismsSchwartz P, Murphy D, Wehr T, Garcia-Borreguero D, Oren D, Moul D, Ozaki N, Snelbaker A, Rosenthal N. Effects of Meta-chlorophenylpiperazine Infusions in Patients With Seasonal Affective Disorder and Healthy Control Subjects: Diurnal Responses and Nocturnal Regulatory Mechanisms. JAMA Psychiatry 1997, 54: 375-385. PMID: 9107154, DOI: 10.1001/archpsyc.1997.01830160103013.
Gender Differences in Depression.Blehar M, Oren D. Gender Differences in Depression. Medscape Journal Of Medicine 1997, 2: 3. PMID: 9746677.
Bilirubin, Rem Sleep, and Phototransduction of Environmental Time Cues. A HypothesisOren D. Bilirubin, Rem Sleep, and Phototransduction of Environmental Time Cues. A Hypothesis. Chronobiology International 1997, 14: 319-329. PMID: 9167892, DOI: 10.3109/07420529709001423.
Restoration of detectable melatonin after entrainment to a 24-hour schedule in a ‘free-running’ manOren D, Giesen H, Wehr T. Restoration of detectable melatonin after entrainment to a 24-hour schedule in a ‘free-running’ man. Psychoneuroendocrinology 1997, 22: 39-52. PMID: 9141150, DOI: 10.1016/s0306-4530(96)00038-8.
Dr. Teicher and Colleagues ReplyTEICHER M, GLOD C, OREN D, SCHWARTZ P, BROWN C, ROSENTHAL N. Dr. Teicher and Colleagues Reply. American Journal Of Psychiatry 1996, 153: 1111-1111. PMID: 8678189, DOI: 10.1176/ajp.153.8.1111.
Humoral Phototransduction: Blood Is a MessengerOren D. Humoral Phototransduction: Blood Is a Messenger. The Neuroscientist 1996, 2: 207-210. DOI: 10.1177/107385849600200408.
Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorderOren D, Levendosky A, Kasper S, Duncan C, Rosenthal N. Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder. Biological Psychiatry 1996, 39: 157-170. PMID: 8837977, DOI: 10.1016/0006-3223(95)00079-8.
Effects of season on electro-oculographic ratio in winter seasonal affective disorderOzaki N, Rosenthal N, Myers F, Schwartz P, Oren D. Effects of season on electro-oculographic ratio in winter seasonal affective disorder. Psychiatry Research 1995, 59: 151-155. PMID: 8771230, DOI: 10.1016/0165-1781(95)02788-2.
Serotonin and ThermoregulationSchwartz P, Wehr T, Rosenthal N, Bartko J, Oren D, Luetke C, Murphy D. Serotonin and Thermoregulation. Neuropsychopharmacology 1995, 13: 105-115. PMID: 8597522, DOI: 10.1016/0893-133x(95)00026-a.
The phototherapy light visor: more to it than meets the eyeTeicher M, Glod C, Oren D, Schwartz P, Luetke C, Brown C, Rosenthal N. The phototherapy light visor: more to it than meets the eye. American Journal Of Psychiatry 1995, 152: 1197-1202. PMID: 7625470, DOI: 10.1176/ajp.152.8.1197.
Abnormal circadian rhythms of plasma melatonin and body temperature in the delayed sleep phase syndrome.Oren D, Turner E, Wehr T. Abnormal circadian rhythms of plasma melatonin and body temperature in the delayed sleep phase syndrome. Journal Of Neurology Neurosurgery & Psychiatry 1995, 58: 379. PMID: 7897427, PMCID: PMC1073383, DOI: 10.1136/jnnp.58.3.379.
Women's increased vulnerability to mood disorders: Integrating psychobiology and epidemiologyBlehar M, Oren D. Women's increased vulnerability to mood disorders: Integrating psychobiology and epidemiology. Depression 1995, 3: 3-12. DOI: 10.1002/depr.3050030103.
1,25 (OH)2 vitamin D3 levels in seasonal affective disorder: Effects of lightOren D, Schulkin J, Rosenthal N. 1,25 (OH)2 vitamin D3 levels in seasonal affective disorder: Effects of light. Psychopharmacology 1994, 116: 515-516. PMID: 7701056, DOI: 10.1007/bf02247486.
A controlled trial of cyanocobalamin (Vitamin B12) in the treatment of winter seasonal affective disorderOren D, Teicher M, Schwartz P, Glod C, Turner E, Ito Y, Sedway J, Rosenthal N, Wehr T. A controlled trial of cyanocobalamin (Vitamin B12) in the treatment of winter seasonal affective disorder. Journal Of Affective Disorders 1994, 32: 197-200. PMID: 7852661, DOI: 10.1016/0165-0327(94)90018-3.
Platelet [3H]paroxetine binding, 5-HT-stimulated Ca2+ response, and 5-HT content in winter seasonal affective disorderOzaki N, Rosenthal N, Mazzola P, Chiueh C, Hardin T, Garcia-Borreguero D, Schwartz P, Turner E, Oren D, Murphy D. Platelet [3H]paroxetine binding, 5-HT-stimulated Ca2+ response, and 5-HT content in winter seasonal affective disorder. Biological Psychiatry 1994, 36: 458-466. PMID: 7811842, DOI: 10.1016/0006-3223(94)90641-6.
SEASONAL AFFECTIVE DISORDER, LIGHT THERAPY, AND THE SEROTONIN SYSTEMRosenthal N, Garcia-Borreguero D, Schwartz P, Jacobsen F, Joseph-Vanderpool J, Oren D, Murphy D. SEASONAL AFFECTIVE DISORDER, LIGHT THERAPY, AND THE SEROTONIN SYSTEM. 1994, 386-391. DOI: 10.1142/9789814440912_0083.
A Controlled Trial of Levodopa Plus Carbidopa in the Treatment of Winter Seasonal Affective DisorderOREN D, MOUL D, SCHWARTZ P, WEHR T, ROSENTHAL N. A Controlled Trial of Levodopa Plus Carbidopa in the Treatment of Winter Seasonal Affective Disorder. Journal Of Clinical Psychopharmacology 1994, 14: 196-200. PMID: 8027416, DOI: 10.1097/00004714-199406000-00007.
Exposure to ambient light in patients with winter seasonal affective disorderOren D, Moul D, Schwartz P, Brown C, Yamada E, Rosenthal N. Exposure to ambient light in patients with winter seasonal affective disorder. American Journal Of Psychiatry 1994, 151: 591-593. PMID: 8147459, DOI: 10.1176/ajp.151.4.591.
EFFECTS OF LIGHT ON T‐CELLS IN HIV‐INFECTED SUBJECTS ARE NOT DEPENDENT ON HISTORY OF SEASONAL AFFECTIVE DISORDERRosenthal N, Brown C, Oren D, Galetto G, Schwartz P, Malley J. EFFECTS OF LIGHT ON T‐CELLS IN HIV‐INFECTED SUBJECTS ARE NOT DEPENDENT ON HISTORY OF SEASONAL AFFECTIVE DISORDER. Photochemistry And Photobiology 1994, 59: 314-319. PMID: 7912442, DOI: 10.1111/j.1751-1097.1994.tb05040.x.
High titers of anti‐epstein‐barr virus DNA polymerase are found in patients with severe fatiguing illnessNatelson B, Ye N, Moul D, Jenkins F, Oren D, Tapp W, Cheng Y. High titers of anti‐epstein‐barr virus DNA polymerase are found in patients with severe fatiguing illness. Journal Of Medical Virology 1994, 42: 42-46. PMID: 8308519, DOI: 10.1002/jmv.1890420109.
Effects of phototherapy on electrooculographic ratio in winter seasonal affective disorderOzaki N, Rosenthal N, Moul D, Schwartz P, Oren D. Effects of phototherapy on electrooculographic ratio in winter seasonal affective disorder. Psychiatry Research 1993, 49: 99-107. PMID: 8153191, DOI: 10.1016/0165-1781(93)90098-2.
Side effects of light therapy in seasonal affective disorderLevitt A, Joffe R, Moul D, Lam R, Teicher M, Lebegue B, Murray M, Oren D, Schwartz P, Buchanan A. Side effects of light therapy in seasonal affective disorder. American Journal Of Psychiatry 1993, 150: 650-652. PMID: 8465886, DOI: 10.1176/ajp.150.4.650.
Spontaneous eye blink rate in winter seasonal affective disorderBarbato G, Moul D, Schwartz P, Rosenthal N, Oren D. Spontaneous eye blink rate in winter seasonal affective disorder. Psychiatry Research 1993, 47: 79-85. PMID: 8516420, DOI: 10.1016/0165-1781(93)90057-n.
A Multicenter Study of the Light Visor for Seasonal Affective Disorder: No Difference in Efficacy Found Between Two Different IntensitiesRosenthal N, Moul D, Hellekson C, Oren D, Frank A, Brainard G, Murray M, Wehr T. A Multicenter Study of the Light Visor for Seasonal Affective Disorder: No Difference in Efficacy Found Between Two Different Intensities. Neuropsychopharmacology 1993, 8: 151-160. PMID: 8471127, DOI: 10.1038/npp.1993.17.
An investigation of ophthalmic function in winter seasonal affective disorderOren D, Moul D, Schwartz P, Alexander J, Yatnada E, Rosenthal N. An investigation of ophthalmic function in winter seasonal affective disorder. Depression 1993, 1: 29-37. DOI: 10.1002/depr.3050010107.
Light visor treament for seasonal affective disorder: A multicenter studyJoffe R, Moul D, Lam R, Levitt A, Teicher M, Lebegue B, Oren D, Buchanan A, Glod C, Murray M, Brown J, Schwartz P. Light visor treament for seasonal affective disorder: A multicenter study. Psychiatry Research 1993, 46: 29-39. PMID: 8464953, DOI: 10.1016/0165-1781(93)90005-2.
Hypernyctohemeral Syndrome after Chronotherapy for Delayed Sleep Phase SyndromeOren D, Wehr T. Hypernyctohemeral Syndrome after Chronotherapy for Delayed Sleep Phase Syndrome. New England Journal Of Medicine 1992, 327: 1762. PMID: 1435929, DOI: 10.1056/nejm199212103272417.
Retinopathy and Bright Light TherapyWAXLER M, JAMES R, BRAINARD G, MOUL D, OREN D, ROSENTHAL N. Retinopathy and Bright Light Therapy. American Journal Of Psychiatry 1992, 149: 1610-b-1611. PMID: 1415836, DOI: 10.1176/ajp.149.11.1610-b.
Predictors of response to phototherapy in seasonal affective disorderOren D, Jacobsen F, Wehr T, Cameron C, Rosenthal N. Predictors of response to phototherapy in seasonal affective disorder. Comprehensive Psychiatry 1992, 33: 111-114. PMID: 1544295, DOI: 10.1016/0010-440x(92)90006-c.
Treatment of seasonal affective disorder with green light and red lightOren D, Brainard G, Johnston S, Joseph-Vanderpool J, Sorek E, Rosenthal N. Treatment of seasonal affective disorder with green light and red light. American Journal Of Psychiatry 1991, 148: 509-511. PMID: 2006698, DOI: 10.1176/ajp.148.4.509.
Usage patterns of phototherapy in seasonal affective disorderOren D, Shannon N, Carpenter C, Rosenthal N. Usage patterns of phototherapy in seasonal affective disorder. Comprehensive Psychiatry 1991, 32: 147-152. PMID: 2022114, DOI: 10.1016/0010-440x(91)90007-y.
Retinal melatonin and dopamine in seasonal affective disorderOren D. Retinal melatonin and dopamine in seasonal affective disorder. Journal Of Neural Transmission 1991, 83: 85-95. PMID: 2018631, DOI: 10.1007/bf01244455.
Adaptation to dim light in depressed patients with seasonal affective disorderOren D, Joseph-Vanderpool J, Rosenthal N. Adaptation to dim light in depressed patients with seasonal affective disorder. Psychiatry Research 1991, 36: 187-193. PMID: 2017533, DOI: 10.1016/0165-1781(91)90130-h.
Exposure to ultraviolet B radiation during phototherapyOren D, Rosenthal F, Rosenthal N, Waxler M, Wehr T. Exposure to ultraviolet B radiation during phototherapy. American Journal Of Psychiatry 1990, 147: 675b-676. PMID: 2327505, DOI: 10.1176/ajp.147.5.675b.
Concerning the Pathogenesis of Idiopathic Hypercalciuria1Broadus AE, Burtis WJ, Oren DA, Sartori L, Gay L, Ellison AF, Insogna KL. Concerning the Pathogenesis of Idiopathic Hypercalciuria1. 1987, 58: 127-136. PMID: 3691116, DOI: 10.1159/000414502.

Edit Profile

Contact Information

Research & Publications

Biography

News

Coauthors

Selected Publications